Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties - PubMed (original) (raw)

Affiliations

PMID: 1650447

Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties

P P Pandolfi et al. Oncogene. 1991 Jul.

Abstract

Acute promyelocytic leukemia (APL) is characterized by the 15;17 chromosomal translocation. Cloning experiments have established that the chromosome 17 breakpoint maps to the RAR alpha and the 15 to the myl locus. The resulting chimeric gene is transcribed as a myl/RAR alpha fusion mRNA. By isolating both normal myl and APL myl/RAR alpha cDNAs, we showed that the myl/RAR alpha mRNA encodes for a putative fusion protein with a molecular weight of about 103 kDa, which is made up of 530 amino acids derived from the myl N-terminus and 402 amino acids originating from the RAR alpha C-terminus. The protein includes the RAR alpha DNA and retinoid-binding regions but lacks the A portion of the N-terminal region (A/B region) which is thought to contain one of the RAR alpha transactivation domains. The myl/RAR alpha protein acted as a retinoid-inducible transcription factor with both ligand-independent repressor and ligand-dependent activator functions in transactivation experiments of a retinoic acid-responsive gene. Myl/RAR alpha exerted this dual function three times more effectively than RAR alpha and had about 10-fold greater affinity for RA than RAR alpha. Comparison of myl/RAR alpha genomic and cDNA sequences from the same case demonstrated that both chromosome 15 and 17 breakpoints occurred within introns and the myl and RAR alpha sequences are spliced in the same polyadenylated RNA.

PubMed Disclaimer

Cited by

PML is required for telomere stability in non-neoplastic human cells.
Marchesini M, Matocci R, Tasselli L, Cambiaghi V, Orleth A, Furia L, Marinelli C, Lombardi S, Sammarelli G, Aversa F, Minucci S, Faretta M, Pelicci PG, Grignani F. Marchesini M, et al. Oncogene. 2016 Apr 7;35(14):1811-21. doi: 10.1038/onc.2015.246. Epub 2015 Jun 29. Oncogene. 2016. PMID: 26119943 Free PMC article.
An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm.
Borden KL, Campbell Dwyer EJ, Salvato MS. Borden KL, et al. J Virol. 1998 Jan;72(1):758-66. doi: 10.1128/JVI.72.1.758-766.1998. J Virol. 1998. PMID: 9420283 Free PMC article.
The interferon-induced antiviral protein PML (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion.
Masroori N, Merindol N, Berthoux L. Masroori N, et al. Retrovirology. 2016 Mar 22;13:19. doi: 10.1186/s12977-016-0253-1. Retrovirology. 2016. PMID: 27000403 Free PMC article.
Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function: a novel mechanism of retinoic acid resistance.
McNamara S, Wang H, Hanna N, Miller WH Jr. McNamara S, et al. Mol Cell Biol. 2008 Mar;28(6):2066-77. doi: 10.1128/MCB.01576-07. Epub 2008 Jan 22. Mol Cell Biol. 2008. PMID: 18212063 Free PMC article.
The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript.
Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M. Miyoshi H, et al. EMBO J. 1993 Jul;12(7):2715-21. doi: 10.1002/j.1460-2075.1993.tb05933.x. EMBO J. 1993. PMID: 8334990 Free PMC article.

Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties - PubMed (original) (raw)